Australia markets closed

10x Genomics, Inc. (TXG)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
16.39-0.17 (-1.03%)
As of 02:39PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts17171717
Avg. Estimate-0.48-0.37-1.59-1.05
Low estimate-0.62-0.59-2.17-1.52
High estimate-0.34-0.23-1.18-0.53
Year ago EPS-0.53-0.79-2.18-1.59
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts15151717
Avg. Estimate150.52M172.62M664.76M754.58M
Low estimate146.56M159.8M637M679.4M
High estimate151.93M177.59M679.4M802.9M
Year ago sales146.82M151.26M618.73M664.76M
Sales growth (year/est)2.50%14.10%7.40%13.50%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.4-0.46-0.36-0.5
Actual EPS-0.53-0.79-0.41-0.5
Difference-0.13-0.33-0.050
Surprise %-32.50%-71.70%-13.90%0.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.48-0.37-1.59-1.05
7 days ago-0.47-0.38-1.6-1.01
30 days ago-0.48-0.38-1.59-1
60 days ago-0.48-0.39-1.61-1.01
90 days ago-0.48-0.37-1.6-0.95
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2222
Down last 7 daysN/AN/AN/AN/A
Down last 30 days2133
Growth estimatesTXGIndustrySector(s)S&P 500
Current qtr.9.40%N/AN/AN/A
Next qtr.53.20%N/AN/AN/A
Current year27.10%N/AN/AN/A
Next year34.00%N/AN/AN/A
Next 5 years (per annum)51.40%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A